Wheeler, Graham M. http://orcid.org/0000-0002-3254-5991
Mander, Adrian P.
Bedding, Alun
Brock, Kristian
Cornelius, Victoria
Grieve, Andrew P.
Jaki, Thomas
Love, Sharon B.
Odondi, Lang’o
Weir, Christopher J.
Yap, Christina
Bond, Simon J.
Funding for this research was provided by:
MRC Network of Hubs for Trials Methodology Research (MR/L004933/1-R/N/P/B1)
Medical Research Council (MC_UP_1302/2)
National Institute for Health Research (NIHR-SRF-2015-08-001)
Cancer Research UK (C5529/A16895, C22436/A15958)
Article History
Received: 4 October 2017
Accepted: 6 December 2018
First Online: 18 January 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AB is an employee and shareholder of Roche Products Ltd. KB owns equity in GlaxoSmithKline and AstraZeneca and has received travel and conference fee reimbursements from Merck and Roche. APG is an employee of UCB Pharma Ltd. All other authors have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.